EDIT: Rasio rega pasar marang bathi resik Editas Medicine Inc

Simbol lan logo merek Editas (EDIT)

Editas Medicine, Inc. (EDIT) maintains its research centers in Massachusetts, while the scaling of drug production relies on US bio-factories. Neutral geopolitics and protection from sanctions provide a stable backdrop for scientific advancement. This price action for the securities on GURU.Markets illustrates a P/E ratio of -3.90, while ownership of key CRISPR patents enables the company to develop unique blood treatment methods.

Editas Medicine (EDIT): Rasio rega marang bathi saka 04.07.2022 nganti 18.11.2026

Rincian analitis perusahaan Editas Medicine, Inc.

- nilai pasar lan prakiraan target analis:
Ringkesan analisis perusahaan:EDIT (Editas Medicine)
Barang unggulan Editas Medicine, Inc.

The long-term reliability of Editas Medicine, Inc. (EDIT) is based on the exclusivity of its CRISPR technologies and high barriers to entry for competitors. The P/E metric determines the business value relative to its net income, reflecting the market valuation of every dollar earned. By analyzing the issuer's P/E ratio, an investor can identify whether the asset is overbought or possesses hidden growth potential. The integration of a unique patent portfolio into these calculations confirms the company's fundamental stability.

Pesaing wigati

tempus.com - Kapitalisasi marang bathi resik|Pangali P/E QGEN|Periode bali modal bisnis Isis Pharmaceuticals|Pangali P/E RGEN (repligen.com)|Rasio rega pasar marang bathi resik RNA (Avidity Biosciences, Inc.)|CRSP - Rasio rega marang bathi|Nilai perusahaan marang bathi resik WGS (GeneDx)|RARE: Pangali P/E|Beam Therapeutics Corp - Nilai perusahaan marang bathi resik|Koefisien rega marang bathi SRPT|twistbioscience.com (TWST) - Periode bali modal bisnis|Pangali P/E TXG|NTLA (Intellia) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Stoke STOK|BioLife (BLFS) - Kapitalisasi marang bathi|wavelifesciences.com - Pangali P/E|Kapitalisasi marang bathi resik MAZE|SION: Pangali P/E|PRME - Periode bali modal bisnis|Koefisien rega marang bathi TSHA|QURE - Rasio kapitalisasi marang bathi resik|Pangali P/E MGTX|Periode bali modal bisnis regenxbio.com|Pangali P/E SLDB (Solid Biosciences Inc)|OCGN: Pangali rega marang bathi|PACB - Rasio rega marang bathi|Benitec (BNTC) - Koefisien rega marang bathi|DSGN: Pangali P/E|RCKT: Rasio rega pasar marang bathi resik|FDMT (4D Molecular Therapeutics, Inc.) - Pangali P/E|lexeotx.com (LXEO) - Periode bali modal bisnis|Pangali P/E KRRO|Periode bali modal bisnis Silence Therapeutics Corp|Rasio rega marang bathi proqr.com PRQR|CDXS - Koefisien rega marang bathi|SGMO - Rasio rega marang bathi|Rasio kapitalisasi marang bathi resik Nautilus Biotechnology, Inc. (NAUT)|MGX: Pangali P/E|Pangali rega marang bathi DTIL|GBIO (Generation Bio) - Pangali P/E|Pangali rega marang bathi BOLD (boundlessbio.com)|Koefisien rega marang bathi XCUR (exicuretx.com)|Celsion Corporation - Pangali rega marang bathi|Pangali P/E PHIO (phiopharma.com)|Pangali P/E Mustang Bio, Inc. MBIO|RNAZ: Koefisien rega marang bathi|BNGO (Bionano Genomics) - Pangali rega marang bathi|APDN: Pangali P/E|bluebird bio (BLUE) - Pangali P/E|Rasio rega marang bathi ImmunoPrecise Antibodies Ltd.|Kapitalisasi marang bathi Omega OMGA|Pangali P/E OMIC|RGLS - Kapitalisasi marang bathi|Syros Pharmaceuticals, Inc - Koefisien rega marang bathi|Periode bali modal bisnis Codex DNA (TBIO)|TCON - Rasio rega marang bathi|UBX: Rasio rega marang bathi